Table 2 Measurement of the residual enzyme activity in control fibroblasts and fibroblasts with MTHFR deficiency using LC-MS/MS.
Enzyme activity LC-MS/MS | |||||||
|---|---|---|---|---|---|---|---|
Standard | − FAD a | ||||||
pmol/min/ mg protein | pmol/min/ mg protein | ||||||
Control (n = 13) | Mean SD Range | 338.5 96.5 240.1–624.0 | 333.2 85.4 213.9–575.4 | ||||
Case | Age b | Sex | Enzyme activity LC-MS/MS | Enzyme activity HPLC-FLD c | Nucleotide change d | Predicted Amino acid change | |
|---|---|---|---|---|---|---|---|
Standard | − FAD a | Standard | |||||
pmol/min/ mg protein e | pmol/min/ mg protein e | pmol/min/ mg protein e | |||||
110 | 2 m | F | 2.99 (0.79%) | 2.28 (0.60%) | 4.50 (1.0%) | c.446_447delinsTT | p.Gly149Val |
211 | 15 y | M | 51.3 (13.6%) | 46.7 (12.4%) | 46.7 (11.1%) | c.446_447delinsTT c.137G > A | p.Gly149Val p.Arg46Gln |
3 | 20 y | M | 7.34 (1.9%) | 7.27 (1.9%) | 11.2 (2.6%) | c.780G > C c.996G > A | p.Gln260His(splicing) p.Val332=(splicing) |
4 | 24 y | M | 34.9 (9.2%) | 37.2 (9.9%) | 32.5 (7.5%) | c.1724T > G | p.Val575Gly |
514 | 35 y | F | 27.5 (7.3%) | 23.8 (6.3%) | 17.5 (4.1%) | c.665 C > T c.673 A > C | p.Ala222Val p.Ile225Leu |